Annual CFF
$143.00 K
-$564.00 K-79.77%
December 31, 2023
Summary
- As of February 12, 2025, QNCX annual cash flow from financing activities is $143.00 thousand, with the most recent change of -$564.00 thousand (-79.77%) on December 31, 2023.
- During the last 3 years, QNCX annual CFF has fallen by -$118.73 million (-99.88%).
- QNCX annual CFF is now -99.88% below its all-time high of $118.88 million, reached on December 31, 2020.
Performance
QNCX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$5.00 M
-$5.04 M-14385.71%
September 30, 2024
Summary
- As of February 12, 2025, QNCX quarterly cash flow from financing activities is -$5.00 million, with the most recent change of -$5.04 million (-14385.71%) on September 30, 2024.
- Over the past year, QNCX quarterly CFF has dropped by -$5.06 million (-8871.93%).
- QNCX quarterly CFF is now -104.24% below its all-time high of $117.85 million, reached on March 31, 2020.
Performance
QNCX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$4.72 M
-$5.01 M-1715.75%
September 30, 2024
Summary
- As of February 12, 2025, QNCX TTM cash flow from financing activities is -$4.72 million, with the most recent change of -$5.01 million (-1715.75%) on September 30, 2024.
- Over the past year, QNCX TTM CFF has dropped by -$4.86 million (-3399.30%).
- QNCX TTM CFF is now -102.42% below its all-time high of $195.15 million, reached on March 31, 2020.
Performance
QNCX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
QNCX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -79.8% | -8871.9% | -3399.3% |
| 3 y3 years | -99.9% | -8871.9% | -3399.3% |
| 5 y5 years | -99.8% | -8871.9% | -3399.3% |
QNCX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.9% | at low | -605.0% | at low | -167.5% | at low |
| 5 y | 5-year | -99.9% | at low | -104.2% | at low | -102.4% | at low |
| alltime | all time | -99.9% | at low | -104.2% | at low | -102.4% | at low |
Quince Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.00 M(<-9900.0%) | -$4.72 M(-1715.8%) |
| Jun 2024 | - | $35.00 K(-81.6%) | $292.00 K(+3.2%) |
| Mar 2024 | - | $190.00 K(+233.3%) | $283.00 K(+97.9%) |
| Dec 2023 | $143.00 K(-79.8%) | $57.00 K(+470.0%) | $143.00 K(+110.3%) |
| Sep 2023 | - | $10.00 K(-61.5%) | $68.00 K(+28.3%) |
| Jun 2023 | - | $26.00 K(-48.0%) | $53.00 K(-60.7%) |
| Mar 2023 | - | $50.00 K(-377.8%) | $135.00 K(-80.9%) |
| Dec 2022 | $707.00 K(-89.6%) | -$18.00 K(+260.0%) | $707.00 K(-58.8%) |
| Sep 2022 | - | -$5000.00(-104.6%) | $1.72 M(-73.3%) |
| Jun 2022 | - | $108.00 K(-82.6%) | $6.42 M(-8.1%) |
| Mar 2022 | - | $622.00 K(-37.2%) | $6.99 M(+2.7%) |
| Dec 2021 | $6.81 M | $990.00 K(-79.0%) | $6.81 M(+16.1%) |
| Sep 2021 | - | $4.71 M(+600.1%) | $5.86 M(+369.8%) |
| Jun 2021 | - | $672.00 K(+52.4%) | $1.25 M(-14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $441.00 K(+880.0%) | $1.47 M(-98.8%) |
| Dec 2020 | $118.88 M(+53.7%) | $45.00 K(-50.0%) | $118.88 M(+0.5%) |
| Sep 2020 | - | $90.00 K(-89.9%) | $118.30 M(+0.1%) |
| Jun 2020 | - | $889.00 K(-99.2%) | $118.21 M(-39.4%) |
| Mar 2020 | - | $117.85 M(<-9900.0%) | $195.15 M(+152.2%) |
| Dec 2019 | $77.37 M(+1.9%) | -$530.00 K(<-9900.0%) | $77.37 M(-0.7%) |
| Sep 2019 | - | $0.00(-100.0%) | $77.89 M(0.0%) |
| Jun 2019 | - | $77.83 M(>+9900.0%) | $77.89 M(+2.8%) |
| Mar 2019 | - | $64.00 K(-740.0%) | $75.75 M(-0.2%) |
| Dec 2018 | $75.93 M(+879.7%) | -$10.00 K(<-9900.0%) | $75.93 M(-0.0%) |
| Sep 2018 | - | $0.00(-100.0%) | $75.94 M(0.0%) |
| Jun 2018 | - | $75.70 M(>+9900.0%) | $75.94 M(>+9900.0%) |
| Mar 2018 | - | $238.00 K | $238.00 K |
| Dec 2017 | $7.75 M | - | - |
FAQ
- What is Quince Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Quince Therapeutics?
- What is Quince Therapeutics annual CFF year-on-year change?
- What is Quince Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Quince Therapeutics?
- What is Quince Therapeutics quarterly CFF year-on-year change?
- What is Quince Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Quince Therapeutics?
- What is Quince Therapeutics TTM CFF year-on-year change?
What is Quince Therapeutics annual cash flow from financing activities?
The current annual CFF of QNCX is $143.00 K
What is the all time high annual CFF for Quince Therapeutics?
Quince Therapeutics all-time high annual cash flow from financing activities is $118.88 M
What is Quince Therapeutics annual CFF year-on-year change?
Over the past year, QNCX annual cash flow from financing activities has changed by -$564.00 K (-79.77%)
What is Quince Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of QNCX is -$5.00 M
What is the all time high quarterly CFF for Quince Therapeutics?
Quince Therapeutics all-time high quarterly cash flow from financing activities is $117.85 M
What is Quince Therapeutics quarterly CFF year-on-year change?
Over the past year, QNCX quarterly cash flow from financing activities has changed by -$5.06 M (-8871.93%)
What is Quince Therapeutics TTM cash flow from financing activities?
The current TTM CFF of QNCX is -$4.72 M
What is the all time high TTM CFF for Quince Therapeutics?
Quince Therapeutics all-time high TTM cash flow from financing activities is $195.15 M
What is Quince Therapeutics TTM CFF year-on-year change?
Over the past year, QNCX TTM cash flow from financing activities has changed by -$4.86 M (-3399.30%)